perfosfamide has been researched along with daunorubicin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andoh, T; Ito, Y; Kawashima, K; Morishima, Y; Morishita, Y; Saito, H; Tanimoto, M; Towatari, M | 1 |
| Ujiie, T | 1 |
| Andreeff, M; Chen, R; Clarkson, BD; Gulati, SC; Lemoli, RM; Tafuri, A | 1 |
| Hanada, R; Hongo, T; Horikoshi, Y; Sakurai, M; Yajima, S | 1 |
| Adachi, K; Marunouchi, T; Saito, H; Towatari, M | 1 |
| Chen, J; Fang, Q; Fei, J; Lin, GW; Lu, HZ; Sun, DJ; Wang, JS; Zhou, XL | 1 |
| Galvan, KA; Penefsky, HS; Souid, AK; Tacka, KA | 1 |
7 other study(ies) available for perfosfamide and daunorubicin
| Article | Year |
|---|---|
Enhanced expression of DNA topoisomerase II by recombinant human granulocyte colony-stimulating factor in human leukemia cells.
Topics: Blotting, Northern; Cyclophosphamide; Daunorubicin; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Etoposide; Gene Expression; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Recombinant Proteins; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured | 1990 |
Immunogenic potential of tumor cells after treatment with antitumor chemotherapeutic agents.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Bleomycin; Cisplatin; Cyclophosphamide; Cytotoxicity, Immunologic; Daunorubicin; Doxorubicin; Female; Immunity, Innate; Immunization; Mice; Mice, Inbred C57BL; Mitomycin; Mitomycins; Neoplasm Transplantation; Nimustine; Nitrosourea Compounds; Spleen; Thymoma; Tumor Cells, Cultured | 1988 |
Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs.
Topics: Antineoplastic Agents; Cell Cycle; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Humans; Interleukin-3; Leukemia, Myeloid, Acute; Male; Tumor Cells, Cultured | 1994 |
In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia.
Topics: Aclarubicin; Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Bone Marrow; Cell Survival; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Follow-Up Studies; Humans; Infant; Infant, Newborn; Life Tables; Melphalan; Methotrexate; Mitomycin; Mitoxantrone; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Recurrence; Remission Induction; Tumor Cells, Cultured; Vincristine | 1997 |
Evidence for a critical role of DNA topoisomerase IIalpha in drug sensitivity revealed by inducible antisense RNA in a human leukaemia cell line.
Topics: Antibiotics, Antineoplastic; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Blotting, Southern; Cell Survival; Cyclophosphamide; Daunorubicin; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Gene Expression; Humans; Isoenzymes; Leukemia, Myeloid; RNA, Antisense; RNA, Messenger; Tumor Cells, Cultured | 1998 |
Genetic modification of hematopoietic progenitor cells for combined resistance to 4-hydroperoxycyclophosphamide, vincristine, and daunorubicin.
Topics: Aldehyde Dehydrogenase; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclophosphamide; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Electroporation; Genes, MDR; Genetic Vectors; Hematopoietic Stem Cells; Retroviridae; Transgenes; Vincristine | 2001 |
Immediate effects of anticancer drugs on mitochondrial oxygen consumption.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Cisplatin; Cyclophosphamide; Daunorubicin; Doxorubicin; HL-60 Cells; Humans; Jurkat Cells; Leukocytes, Mononuclear; Mitochondria; Oxygen Consumption | 2003 |